We are live on ! Find out more
CATX icon

Perspective Therapeutics
CATX

43 hedge funds and large institutions have $5.19M invested in Perspective Therapeutics in 2022 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 7 increasing their positions, 9 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 4

10% more funds holding

Funds holding: 39 → 43 (+4)

0.06% more ownership

Funds ownership: 1.12% → 1.18% (+0.06%)

10% less capital invested

Capital invested by funds: $5.79M → $5.19M (-$597K)

22% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 9

Holders
43
Holders Change
+4
Holders Change %
+10.26%
% of All Funds
0.72%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
7
Reduced
9
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
VCM
Venator Capital Management
Ontario, Canada
+$168K
2
TMWM
Taylor & Morgan Wealth Management
Michigan
+$68.8K
3
PCM
Perkins Capital Management
Minnesota
+$35.4K
4
TSS
Two Sigma Securities
New York
+$9.69K
5
VF
Virtu Financial
New York
+$7.47K

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$26.2K
2
Renaissance Technologies
Renaissance Technologies
New York
-$12.3K
3
BIM
Bullseye Investment Management
Ohio
-$9K
4
Northern Trust
Northern Trust
Illinois
-$5.25K
5
TRCT
Tower Research Capital (TRC)
New York
-$5K
Name Holding Trade Value Shares
Change 		Change in
Stake
VF
26
Virtu Financial
New York
$8K +$7.47K +2,447 New
Victory Capital Management
27
Victory Capital Management
Texas
$6K -$43 -14 -0.7%
Ameriprise
28
Ameriprise
Minnesota
$6K – – –
TWM
29
TMD Wealth Management
Arizona
$6K – – –
Jane Street
30
Jane Street
New York
$6K +$2.67K +874 +73%
RJFSA
31
Raymond James Financial Services Advisors
Florida
$5K – – –
UBS Group
32
UBS Group
Switzerland
$5K +$5.13K +1,678 +2,468%
AAM
33
Auxier Asset Management
Oregon
$4K – – –
GVAG
34
Great Valley Advisor Group
Delaware
$4K +$3.67K +1,200 New
CAI
35
Capital Advisors Inc
Oklahoma
$3K – – –
WE
36
Wealth Effects
Massachusetts
$3K – – –
Wells Fargo
37
Wells Fargo
California
$2K -$6 -2 -0.3%
JFA
38
JNBA Financial Advisors
Minnesota
$2K – – –
TWC
39
TD Waterhouse Canada
Ontario, Canada
$584 – – –
AIA
40
Arcadia Investment Advisors
Idaho
$69 – – –
BIM
41
Bullseye Investment Management
Ohio
– -$9K -2,500 Closed
TRCT
42
Tower Research Capital (TRC)
New York
– -$5K -1,380 Closed
DWA
43
Douglass Winthrop Advisors
New York
– -$4K -1,000 Closed
Northwestern Mutual Wealth Management
44
Northwestern Mutual Wealth Management
Wisconsin
– +$24 +8 New
CCM
45
Chilton Capital Management
Texas
– +$153 +50 New
Bank of America
46
Bank of America
North Carolina
– +$305 +100 New
1
2

CATX Hedge Fund Activity: Q2 2022 in Review

43 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Perspective Therapeutics (CATX) for Q2 2022, worth a combined $5.19M — down 10% from $5.79M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new CATX positions and 4 closed out — a net gain of 4 holders — while 7 added to existing stakes and 9 trimmed.

The largest buyer was Venator Capital Management, opening a new position worth an estimated $168K. The largest seller was Citadel Advisors, cutting an estimated $26.2K.

  • 43 institutional investors held Perspective Therapeutics (CATX) as of Q2 2022, up from 39 in Q1 2022.
  • Funds reported $5.19M of Perspective Therapeutics stock for Q2 2022, down 10% quarter-over-quarter.
  • 8 funds opened new Perspective Therapeutics positions in Q2 2022 and 4 closed out, a net change of +4 holders.
  • The largest Perspective Therapeutics buyer in Q2 2022 was Venator Capital Management, an estimated $168K added.
  • The largest Perspective Therapeutics seller in Q2 2022 was Citadel Advisors, an estimated $26.2K sold.

Based on aggregated 13F filings for Q2 2022.